In this webinar, we explore how Home Care Support functions as a performance driver in Decentralized Clinical Trials (DCTs).
After briefly introducing Invisio and our international infrastructure, we outline why decentralization does not reduce complexity but rather shifts operational burden from sites to patients and coordination structures. We then demonstrate how structured home care visits stabilize trial execution and generate measurable effects on patient retention, study timelines, and data quality.
In the core section, we present the economic perspective, showing how reduced dropout rates, minimized delays, and lower monitoring effort translate into significant cost savings for sponsors. The webinar concludes with a concrete ROI scenario that transparently illustrates the financial impact of integrating home care support into decentralized trial models.
